主动脉壁血栓对开窗分支支架腔内修复术后患者远期肾功能变化的影响
本研究基于2007—2015年前瞻性数据库,纳入212例肾旁或IV型胸腹主动脉瘤行开窗分支腔内修复术患者,用CT血管造影容积法将主动脉壁血栓(AWT)分为轻、中、重三度。结果显示AWT严重程度与30天急性肾损伤(AKI)及远期肾功能恶化相关,AWT与30天死亡无关联,生存率三组间无显著差异。
要点
- AWT重度患者3年无肾功能恶化率为66%±8%,低于中度患者的81%±6%和轻度患者的73%±6%(P=0.012)。
- 术后发生AKI者3年无肾功能恶化率为46%±9%,未发生AKI者为82%±4%(P<0.001)。
- AWT与30天死亡无关联,全队列30天死亡率为0.5%。
核心结论
- AWT是F-BEVAR术后AKI及肾功能持续下降的显著预测因素。
- 需要更长的随访时间来确定AWT对生存的实际影响。
研究设计与样本
- 研究类型为基于2007—2015年前瞻性维护数据库的临床数据分析,纳入212例因复杂主动脉瘤行开窗分支腔内修复术(F-BEVAR)的患者。
- AWT通过CT血管造影在非动脉瘤主动脉段进行容积测量评估,并按受累段数、血栓类型、厚度、面积和周长客观分为轻度、中度、重度。
- AKI采用RIFLE标准定义,肾功能恶化定义为估算肾小球滤过率(eGFR)较基线下降>30%。
- 随访在出院时、6—8周、6个月及每年进行,评估AKI、血清肌酐、eGFR、慢性肾脏病分期、肾脏替代治疗需求及肾梗死。
主要发现
- 共169例男性(80%)和43例女性(20%),平均年龄75±7岁;动脉瘤范围为肾旁157例、IV型胸腹主动脉瘤55例;共重建700条肾-肠系膜动脉(3.1±1条/例)。
- AWT分类为轻度98例(46%)、中度75例(35%)、重度39例(19%);30天内45例(21%)发生AKI。
- eGFR下降和肾梗死与更高的AWT容积指数及重度AWT分类相关(P<0.05);AWT与30天死亡无关联,全队列30天死亡率为0.5%。
- 平均随访29±23个月;3年无肾功能恶化率轻度为73%±6%、中度为81%±6%、重度为66%±8%(P=0.012);术后发生AKI者3年无肾功能恶化率为46%±9%,未发生AKI者为82%±4%(P<0.001)。
- 共41例(19%)慢性肾脏病分期进展,但无患者需要肾脏替代治疗;3年生存率轻度为73%±5%、中度为72%±6%、重度为69%±10%(P=0.67)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需要更长的随访时间来确定AWT对生存的实际影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Renal function deterioration is an important determinant of mortality in patients treated for complex aortic aneurysms. We have previously determined that catheter and guidewire manipulation in diseased aortas during fenestrated-branched endovascular aneurysm repair (F-BEVAR) is associated with risk of renal function deterioration. The aim of this study was to describe the impact of atherothrombotic aortic wall thrombus (AWT) on renal function deterioration among patients treated by F-BEVAR for pararenal and extent IV thoracoabdominal aortic aneurysms. METHODS: Clinical data of 212 patients treated for complex aortic aneurysms with F-BEVAR were entered into a prospectively maintained database (2007-2015). AWT was evaluated by computed tomography angiography using volumetric measurements in nonaneurysmal aortic segments. AWT was classified as mild, moderate, or severe using objective assessment of the number of affected segments, thrombus type, thickness, area, and circumference. Acute kidney injury (AKI) was defined using Risk, Injury, Failure, Loss of kidney function, and End-stage renal disease (RIFLE) criteria, and renal function deterioration was defined by a decline in estimated glomerular filtration rate (eGFR) >30% from baseline. Patient survival and renal outcomes were assessed at dismissal, at 6 to 8 weeks, at 6 months, and annually, including AKI, serum creatinine concentration, eGFR, chronic kidney disease stage, need for renal replacement therapy, and presence of kidney infarction. RESULTS: There were 169 male (80%) and 43 female (20%) patients with a mean age of 75 ± 7 years. Aneurysm extent was pararenal in 157 patients and extent IV thoracoabdominal aortic aneurysm in 55 patients. A total of 700 renal-mesenteric arteries were incorporated (3.1 ± 1 vessels/patient). AWT was classified as mild in 98 patients (46%), moderate in 75 (35%), and severe in 39 (19%). At 30 days, 45 patients (21%) developed AKI. Decline in eGFR and kidney infarction were associated with higher AWT volume index and severe AWT classification (P < .05). There was no association of AWT with 30-day mortality, which was 0.5% for the entire cohort. Mean follow-up was 29 ± 23 months. Freedom from renal function deterioration was 73% ± 6% for mild, 81% ± 6% for moderate, and 66% ± 8% for severe AWT patients at 3 years (P = .012) and 46% ± 9% and 82% ± 4% for those with or without AKI after the initial procedure (P < .001). Overall, 41 patients (19%) had progression of chronic kidney disease stage, but none of the patients required renal replacement therapy. Survival was 73% ± 5% for mild, 72% ± 6% for moderate, and 69% ± 10% for severe AWT patients at 3 years (P = .67). CONCLUSIONS: AWT is a significant predictor of AKI and continued decline in renal function after the initial F-BEVAR procedure. Longer follow-up time is needed to determine the actual impact of AWT on survival.
引用
- Sandri GA, Oderich GS, Tenorio ER, et al. Impact of aortic wall thrombus on late changes in renal function among patients treated by fenestrated-branched endografts. J Vasc Surg. 2018. PMID: 30154012. doi:10.1016/j.jvs.2018.05.243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。